History

Eclosion was created in 2004 as a "proof-of-concept" fund to exploit the entrepreneurial opportunity to translate breakthrough academic discoveries into disruptive therapeutic products.

Eclosion2 was launched in 2011 to build up on the success of Eclosion and continue the launch and growth of new companies developing life-altering drugs.